Synopsis
0
CEP/COS
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Calcium Resonium
2. Kalimate
3. Kayexalate
4. Poly(styrenesulfonate)
5. Polystyrene Sulfonate
6. Polystyrene Sulfonic Acid
7. Polystyrene Sulfonic Acid, Homopolymer, Calcium Salt
8. Psso3
9. Resonium-a
1. 37286-92-3
2. Calciumpolystyrenesulphonate
3. Calcium;2-ethenylbenzenesulfonate
4. Kalimate
5. Kmp-ca
6. Calcium Polystyrene Sulfonate [jan]
7. Calcium Salt Of Sulfonated Styrene Polymer
8. Unii-hui2s00793
9. Benzenesulfonic Acid, Ethenyl-, Homopolymer, Calcium Salt
10. Hui2s00793
11. B2699-019837
12. Calcium Polystyrene Sulfonate (poly(styrenesulfonic Acid) Calcium Salt)
Molecular Weight | 223.28 g/mol |
---|---|
Molecular Formula | C8H7CaO3S+ |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 222.9741811 g/mol |
Monoisotopic Mass | 222.9741811 g/mol |
Topological Polar Surface Area | 65.6 Ų |
Heavy Atom Count | 13 |
Formal Charge | 1 |
Complexity | 237 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cation Exchange Resins
High molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions with cations. (See all compounds classified as Cation Exchange Resins.)
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37063
Submission : 2022-05-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23125
Submission : 2009-09-22
Status : Active
Type : II
Date of Issue : 2022-09-12
Valid Till : 2025-02-07
Written Confirmation Number : WC-0132
Address of the Firm :
NDC Package Code : 55363-404
Start Marketing Date : 2012-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21725
Submission : 2008-03-26
Status : Inactive
Type : II
Registration Number : 227MF10297
Registrant's Address : Str. Aleeea Uzinei Nr. 11, 505700 Victoria, Judetul Brasov, Romania
Initial Date of Registration : 2015-12-28
Latest Date of Registration :
Registrant Name : Leaders Bio Co., Ltd.
Registration Date : 2023-04-24
Registration Number : 20230424-211-J-1482
Manufacturer Name : Purolite SRL
Manufacturer Address : Str. Aleea Uzinei, Nr.11, Victoria, Jud. Braşov 505700 Romania
Date of Issue : 2023-06-04
Valid Till : 2025-12-27
Written Confirmation Number : WC-0393
Address of the Firm :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Registration Number : 229MF10142
Registrant's Address : 10-2 Yoshida Shimojima, Higashiosaka City, Osaka Prefecture
Initial Date of Registration : 2017-07-25
Latest Date of Registration :
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Company : Cmp Pharma, Inc*
Sodium Polystyrene Sulfon/Sorb
Drug Cost (USD) : 13,628,800
Year : 2023
Prescribers : 59552
Prescriptions : 107002
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Eci Pharmaceuti
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 679,550
Year : 2022
Prescribers : 4927
Prescriptions : 7671
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Epic Pharma LLC
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 39,770
Year : 2022
Prescribers : 302
Prescriptions : 426
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : KVK-Tech, Inc.
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 1,474,303
Year : 2022
Prescribers : 13588
Prescriptions : 20641
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Marlex Pharm.
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 22,129
Year : 2022
Prescribers : 195
Prescriptions : 303
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Cmp Pharma, Inc
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 37,298
Year : 2022
Prescribers : 283
Prescriptions : 529
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Cmp Pharma, Inc*
Sodium Polystyrene Sulfon/Sorb
Drug Cost (USD) : 11,577,377
Year : 2022
Prescribers : 61509
Prescriptions : 110468
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Sunrise Pharmac
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 1,149,053
Year : 2022
Prescribers : 14397
Prescriptions : 23091
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Eci Pharmaceuti
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 990,937
Year : 2021
Prescribers : 6964
Prescriptions : 11856
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Epic Pharma LLC
Sodium Polystyrene Sulfonate
Drug Cost (USD) : 48,663
Year : 2021
Prescribers : 320
Prescriptions : 544
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
ABOUT THIS PAGE
68
PharmaCompass offers a list of Calcium Polystyrene Sulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Polystyrene Sulfonate manufacturer or Calcium Polystyrene Sulfonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Polystyrene Sulfonate manufacturer or Calcium Polystyrene Sulfonate supplier.
PharmaCompass also assists you with knowing the Calcium Polystyrene Sulfonate API Price utilized in the formulation of products. Calcium Polystyrene Sulfonate API Price is not always fixed or binding as the Calcium Polystyrene Sulfonate Price is obtained through a variety of data sources. The Calcium Polystyrene Sulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SPS manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SPS, including repackagers and relabelers. The FDA regulates SPS manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SPS API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of SPS manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A SPS supplier is an individual or a company that provides SPS active pharmaceutical ingredient (API) or SPS finished formulations upon request. The SPS suppliers may include SPS API manufacturers, exporters, distributors and traders.
click here to find a list of SPS suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A SPS DMF (Drug Master File) is a document detailing the whole manufacturing process of SPS active pharmaceutical ingredient (API) in detail. Different forms of SPS DMFs exist exist since differing nations have different regulations, such as SPS USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A SPS DMF submitted to regulatory agencies in the US is known as a USDMF. SPS USDMF includes data on SPS's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The SPS USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of SPS suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The SPS Drug Master File in Japan (SPS JDMF) empowers SPS API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the SPS JDMF during the approval evaluation for pharmaceutical products. At the time of SPS JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of SPS suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a SPS Drug Master File in Korea (SPS KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of SPS. The MFDS reviews the SPS KDMF as part of the drug registration process and uses the information provided in the SPS KDMF to evaluate the safety and efficacy of the drug.
After submitting a SPS KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their SPS API can apply through the Korea Drug Master File (KDMF).
click here to find a list of SPS suppliers with KDMF on PharmaCompass.
A SPS written confirmation (SPS WC) is an official document issued by a regulatory agency to a SPS manufacturer, verifying that the manufacturing facility of a SPS active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting SPS APIs or SPS finished pharmaceutical products to another nation, regulatory agencies frequently require a SPS WC (written confirmation) as part of the regulatory process.
click here to find a list of SPS suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing SPS as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for SPS API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture SPS as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain SPS and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a SPS NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of SPS suppliers with NDC on PharmaCompass.
SPS Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SPS GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SPS GMP manufacturer or SPS GMP API supplier for your needs.
A SPS CoA (Certificate of Analysis) is a formal document that attests to SPS's compliance with SPS specifications and serves as a tool for batch-level quality control.
SPS CoA mostly includes findings from lab analyses of a specific batch. For each SPS CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SPS may be tested according to a variety of international standards, such as European Pharmacopoeia (SPS EP), SPS JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SPS USP).